U.S. Markets open in 6 hrs 34 mins

Albany Molecular Research, Inc. (AMRI)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
16.01-0.57 (-3.44%)
At close: 4:00PM EDT
People also watch
ARQLARRYALKSENZNANIK
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close16.58
Open16.70
Bid16.05 x 200
Ask16.70 x 200
Day's Range15.39 - 16.76
52 Week Range12.45 - 19.35
Volume1,824,189
Avg. Volume626,185
Market Cap667.39M
Beta0.69
PE Ratio (TTM)-8.74
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals4 days ago

    Report: AMRI considering $1 billion sale

    Drug manufacturer Albany Molecular Research Inc. is looking at a $1 billion sale, according to Bloomberg News. AMRI is working with Credit Suisse Group AG to explore a sale, Bloomberg reports, citing unidentified sources. Carlyle Group LP and Pamplona Capital Management, two private equity firms with records of investing in pharmaceutical and health care deals, have expressed interest.

  • Capital Cube23 days ago

    ETFs with exposure to Albany Molecular Research, Inc. : April 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Albany Molecular Research, Inc. Here are 5 ETFs with the largest exposure to AMRI-US. Comparing the performance and risk of Albany Molecular Research, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • 3 Biotech Stocks to Buy in March
    Motley Fool2 months ago

    3 Biotech Stocks to Buy in March

    Why Spark Therapeutics, Albany Molecular Research, and Concert Pharmaceuticals could be great biotech stocks to buy as spring approaches.